Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

49 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Performance of whole genome sequencing for respiratory syncytial virus: insights from the first external quality assessment, France, 2024.
Moisan A, Regue H, Rahou Y, Gaymard A, Oblette A, Avon L, Bergaud N, Chalvignac R, Le Hingrat Q, Burrel S, Jary A, Colson P, Cappy P, Deroche L, Brodard V, Pronier C, Alessandri-Gradt E, Salmona M, Chollet L, Trémeaux P, Handala L, Fourati S, Lina B, Casalegno JS, Rameix-Welti MA, Josset L, Bal A; collaborative group; Bichat; Houhou N, Guilbaud R, Saint-Joannis T; Bordeaux; La Pitié-Salpêtrière; Marseille; Mondor; Reims; Rennes; Rouen; Saint-Louis; Toulon; Poggi C, Toyer AL, Domine M, Gardan V; Toulouse; Carcenac R, Demmou S, Latour J, Vellas C; Tours; Lyon; Pasteur; ANRS-MIE Technology working group. Moisan A, et al. Among authors: tremeaux p. Clin Microbiol Infect. 2024 Dec 24:S1198-743X(24)00605-0. doi: 10.1016/j.cmi.2024.12.018. Online ahead of print. Clin Microbiol Infect. 2024. PMID: 39725080 No abstract available.
Genotypic and phenotypic characterisation of respiratory syncytial virus after nirsevimab breakthrough infections: a large, multicentre, observational, real-world study.
Fourati S, Reslan A, Bourret J, Casalegno JS, Rahou Y, Chollet L, Pillet S, Tremeaux P, Dossou NC, Gault E, Salmona M, Imbert-Marcille BM, Mirand A, Larrat S, Moisan A, Marot S, Schnuriger A, Veyrenche N, Engelmann I, Handala L, Henry A, Stephan V, Brichler S, Avettand-Fenoel V, Zemali N, Lefeuvre C, Pronier C, Deroche L, Jaffar-Bandjee MC, Mouna L, Francois C, Regueme A, Hartard C, Rogez S, Gallais F, Ly A, Rodriguez C, Dos Santos G, Simon-Loriere E, Schwartz O, Buchrieser J, Pawlotsky JM, Lemoine F, Audureau E, Rameix-Welti MA; POLYRES investigators. Fourati S, et al. Among authors: tremeaux p. Lancet Infect Dis. 2024 Oct 14:S1473-3099(24)00570-X. doi: 10.1016/S1473-3099(24)00570-X. Online ahead of print. Lancet Infect Dis. 2024. PMID: 39419046
Resistance mutations in SARS-CoV-2 omicron variant in patients treated with sotrovimab.
Vellas C, Trémeaux P, Del Bello A, Latour J, Jeanne N, Ranger N, Danet C, Martin-Blondel G, Delobel P, Kamar N, Izopet J. Vellas C, et al. Among authors: tremeaux p. Clin Microbiol Infect. 2022 Sep;28(9):1297-1299. doi: 10.1016/j.cmi.2022.05.002. Epub 2022 May 17. Clin Microbiol Infect. 2022. PMID: 35595125 Free PMC article. No abstract available.
Whole-genome single molecule real-time sequencing of SARS-CoV-2 Omicron.
Nicot F, Trémeaux P, Latour J, Carcenac R, Demmou S, Jeanne N, Ranger N, De Smet C, Raymond S, Dimeglio C, Izopet J. Nicot F, et al. Among authors: tremeaux p. J Med Virol. 2023 Feb;95(2):e28564. doi: 10.1002/jmv.28564. J Med Virol. 2023. PMID: 36756931
Early assessment of diffusion and possible expansion of SARS-CoV-2 Lineage 20I/501Y.V1 (B.1.1.7, variant of concern 202012/01) in France, January to March 2021.
Gaymard A, Bosetti P, Feri A, Destras G, Enouf V, Andronico A, Burrel S, Behillil S, Sauvage C, Bal A, Morfin F, Van Der Werf S, Josset L; ANRS MIE AC43 COVID-19; French viro COVID group; Blanquart F, Coignard B, Cauchemez S, Lina B. Gaymard A, et al. Euro Surveill. 2021 Mar;26(9):2100133. doi: 10.2807/1560-7917.ES.2021.26.9.2100133. Euro Surveill. 2021. PMID: 33663644 Free PMC article.
Impact of Casirivimab-Imdevimab on Severe Acute Respiratory Syndrome Coronavirus 2 Delta Variant Nasopharyngeal Virus Load and Spike Quasispecies.
Vellas C, Del Bello A, Gaube G, Tremeaux P, Jeanne N, Ranger N, Martin-Blondel G, Delobel P, Kamar N, Izopet J. Vellas C, et al. Among authors: tremeaux p. Open Forum Infect Dis. 2022 Feb 21;9(4):ofac093. doi: 10.1093/ofid/ofac093. eCollection 2022 Apr. Open Forum Infect Dis. 2022. PMID: 35299988 Free PMC article.
49 results